Document Detail


High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
MedLine Citation:
PMID:  10586909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Organic pentavalent antimonials are one of the mainstays of treatment for visceral leishmaniasis (VL). Few data are available on the toxicity and efficacy of these drugs at the dosing schedule recommended by the Centers for Disease Control and Prevention (CDC) (Atlanta, GA). We analyzed 25 VL episodes in human immunodeficiency virus (HIV)-infected patients who were treated with meglumine antimoniate (MA) at the CDC-recommended dose in southern Spain. Adverse effects were observed in 14 (56%) VL episodes. In 7 (28%), treatment with MA was permanently discontinued due to serious adverse effects that included acute pancreatitis, acute renal failure, and leukopenia. Three (12%) patients died during therapy due to severe acute pancreatitis attributable to MA. The dosing regimen of MA currently recommended for treating VL is associated with a high rate of serious side effects in HIV-1-infected patients.
Authors:
J Delgado; J Macías; J A Pineda; J E Corzo; M P González-Moreno; R de la Rosa; A Sánchez-Quijano; M Leal; E Lissen
Related Documents :
8979059 - Papillary roof incision using the erlangen-type pre-cut papillotome to achieve selectiv...
19730769 - Prospective randomized pilot trial comparing closed suction drainage and gravity draina...
10207239 - Distal pancreatectomy in chronic pancreatitis.
23419449 - Effects on the quality of compression-only, cardiopulmonary resuscitation performance a...
23104609 - Intraoperative determinants of rotator cuff repair integrity: an analysis of 500 consec...
23373869 - Remnant uptake as a postoperative oncologic quality indicator.
2853459 - Prevention of postoperative venous thrombosis: a randomized trial comparing unfractiona...
3886069 - Chronic pilonidal disease: a randomized trial with a complete 3-year follow-up.
18197359 - Change over time of mortality predictors after haart initiation in a senegalese cohort.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of tropical medicine and hygiene     Volume:  61     ISSN:  0002-9637     ISO Abbreviation:  Am. J. Trop. Med. Hyg.     Publication Date:  1999 Nov 
Date Detail:
Created Date:  1999-12-21     Completed Date:  1999-12-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370507     Medline TA:  Am J Trop Med Hyg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  766-9     Citation Subset:  AIM; IM; X    
Affiliation:
Departamento de Medicina Interna, Hospital Universitario Virgen del Rocío, Seville, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amylases / blood
Animals
Antimony / administration & dosage,  adverse effects,  therapeutic use
Antiprotozoal Agents / administration & dosage,  adverse effects*,  therapeutic use
Bone Marrow / parasitology
Creatinine / blood
Female
HIV Infections / complications*
HIV-1*
Humans
Leishmania infantum / drug effects*
Leishmaniasis, Visceral / complications,  drug therapy*
Leukocyte Count
Male
Meglumine / administration & dosage,  adverse effects*,  therapeutic use
Organometallic Compounds / administration & dosage,  adverse effects*,  therapeutic use
Pancreatitis / chemically induced
Recurrence
Retrospective Studies
Vomiting
Chemical
Reg. No./Substance:
0/Antiprotozoal Agents; 0/Organometallic Compounds; 133-51-7/meglumine antimoniate; 60-27-5/Creatinine; 6284-40-8/Meglumine; 7440-36-0/Antimony; EC 3.2.1.-/Amylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schi...
Next Document:  Anti-malarial drug use among preschool children in an area of seasonal malaria transmission in Kenya...